WebDec 21, 2024 · “In the meantime, Pourhassan allegedly sold approximately $15.8 million worth of CytoDyn stock based on the false information, netting profits of more than $4.7 million,” the Securities and ... WebDec 20, 2024 · The Securities and Exchange Commission today charged Nader Pourhassan, the former CEO of CytoDyn Inc., with fraud and insider trading in …
CytoDyn Hit with Securities Class Action Over Alleged ‘Hyping’ …
WebJan 26, 2024 · CytoDyn CFO and interim president Antonio Migliarese. (CytoDyn Photo) Nader Pourhassan has been ousted as CEO and president by the board of directors of … WebMay 17, 2024 · CytoDyn has conducted two separate clinical trials investigating leronlimab for the treatment of COVID-19. A smaller trial, titled CD10, which included 86 patients, studied leronlimab’s effect ... does jerky go bad
Investigation announced for Long-Term Investors in CytoDyn
WebOct 7, 2024 · CytoDyn intends to file with the SEC a definitive proxy statement and associated proxy card in connection with the solicitation of proxies for the Company’s … Webfilings with the United States Securities and Exchange Commission (“SEC”) made by CytoDyn; (ii) research reports by securities and financial analysts and investors; (iii) articles published by ... Court-appointed Lead Counsel’s investigation into the factual allegations contained herein is ongoing. Many of the relevant facts are known ... WebApr 14, 2024 · Further, the complaint, filed in Washington federal court, alleges CytoDyn, in addition to “overstating the viability of Leronlimab as a COVID-19 treatment,” also engaged in a wrongful scheme with its lender, non-party Iliad Research and Trading L.P., and its principal whereby the entities operated as an unregistered securities dealer for ... damascus road project oshkosh